medigraphic.com
SPANISH

Annals of Hepatology

Órgano Oficial de la Asociación Mexicana de Hepatología
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2012, Number 5

<< Back Next >>

Ann Hepatol 2012; 11 (5)

Shark liver oil: hidden dangers

Kilincalp S, Deveci M, Basar O, Ekiz F, Coban S, Yuksel O
Full text How to cite this article

Language: English
References: 8
Page: 728-730
PDF size: 63.44 Kb.


Key words:

No keywords

Text Extraction

Dear Editor:
An estimated 80% of the world population uses herbal and supplementary medicines. Herbal toxicity due to herbal products is a rare but well-known adverse event. However less is known about the effects of other phytotherapics. Among these is shark liver oil, a popular over-the-counter Asian and Mediterranean folk remedy, which has been in use for over 40 years as both a therapeutic and preventive agent.


REFERENCES

  1. Stickel F, Patsenker E, Schuppan D. Herbal hepatotoxicity. J Hepatology 2005; 43: 901-10.

  2. Berdel WE, Bausert WR, Weltzien HU, Modotell ML, Widmann KH, Munder PG. The influence of alkyl-lysophospholipids and lysophospholipid activated macrophages on the development of metastasis of 3-Lewis lung carcinoma. Eur J Cancer 1980; 16: 1199-204.

  3. Finkelstein JB. Sharks do get cancer: few surprises in cartilage research. J Natl Cancer Inst 2005; 97: 1562-3.

  4. Deniau AL, Mosset P, Pédrono F, Mitre R, Le Bot D, Legrand AB. Multiple beneficial health effects of natural alkylglycerols from shark liver oil. Mar Drugs 2010; 8: 2175-84.

  5. Davidson BC, Rottanburg D, Prinz W, Cliff G. The influence of shark liver oils on normal and transformed mammalian cells in culture. In Vivo 2007; 21: 333-7.

  6. Dosay-Akbulut M. The determination of the specific characteristics on the immunosurveilance against to cancer formation in elasmobranches. Int J Cancer Res 2006; 2: 119-23.

  7. Sacks FM, Stone PH, Gibson CM, et al. Controlled trial of fish oil for regression of human coronary atherosclerosis. HARP Research Group. J Am Coll Cardiol 1995; 25: 1492.

  8. Teschke R, Schwarzenboeck A, Hennermann KH. Causality assessment in hepatotoxicity by drugs and dietary suplements. Br J Clin Pharmacol 2008; 66: 758-66.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ann Hepatol. 2012;11